Is my portfolio
One Report to Answer all your Questions!
Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
927.15
3.50 (0.38%) Natco Pharma - Quaterly Results
Date: 09-08-2022
The Total revenue for the quarter ended June 2022 of Rs. 8057.00 millions grew by 104.60% from Rs. 3938.00 millions.The Total revenue for the quarter ended June 2022 of Rs. 3080.00 millions grew by 309.57% from Rs. 752.00 millions.OP of the company witnessed a marginal growth to 4126.00 millions from 1259.00 millions in the same quarter last year.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202206 | 202106 | % Var | 202206 | 202106 | % Var | 202203 | 202103 | % Var | |
| Sales | 8057.00 | 3938.00 | 104.60 | 8057.00 | 3938.00 | 104.60 | 17678.00 | 16535.00 | 6.91 |
| Other Income | 332.00 | 123.00 | 169.92 | 332.00 | 123.00 | 169.92 | 946.00 | 1011.00 | -6.43 |
| PBIDT | 4126.00 | 1259.00 | 227.72 | 4126.00 | 1259.00 | 227.72 | 3076.00 | 5187.00 | -40.70 |
| Interest | 27.00 | 18.00 | 50.00 | 27.00 | 18.00 | 50.00 | 133.00 | 113.00 | 17.70 |
| PBDT | 4099.00 | 1241.00 | 230.30 | 4099.00 | 1241.00 | 230.30 | 2943.00 | 5074.00 | -42.00 |
| Depreciation | 369.00 | 331.00 | 11.48 | 369.00 | 331.00 | 11.48 | 1384.00 | 1152.00 | 20.14 |
| PBT | 3730.00 | 910.00 | 309.89 | 3730.00 | 910.00 | 309.89 | 1559.00 | 3922.00 | -60.25 |
| TAX | 650.00 | 158.00 | 311.39 | 650.00 | 158.00 | 311.39 | 168.00 | 827.00 | -79.69 |
| Deferred Tax | -10.00 | 3.00 | -433.33 | -10.00 | 3.00 | -433.33 | -157.00 | -106.00 | 48.11 |
| PAT | 3080.00 | 752.00 | 309.57 | 3080.00 | 752.00 | 309.57 | 1391.00 | 3095.00 | -55.06 |
| Equity | 365.00 | 365.00 | 0.00 | 365.00 | 365.00 | 0.00 | 365.00 | 365.00 | 0.00 |
| PBIDTM(%) | 51.21 | 31.97 | 60.18 | 51.21 | 31.97 | 60.18 | 17.40 | 31.37 | -44.53 |